Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zurzuvae
Pharma
Sage discontinues Zulresso, drops pair of pipeline prospects
The company this week revealed that it’s discontinuing a commercial medicine and giving up hopes for a pair of pipeline prospects.
Eric Sagonowsky
Oct 30, 2024 8:55am
Sage 'highly encouraged' by Zurzuvae launch with Biogen
Feb 14, 2024 1:21pm
After 40% reduction in workforce, Sage will shift to smaller HQ
Jan 25, 2024 10:55am
Sage, Biogen call an audible on pricing strategy for Zurzuvae
Nov 7, 2023 3:24pm
Biogen, Sage receive bittersweet news from the FDA
Aug 7, 2023 10:01am
Top 10 most anticipated drug launches of 2023
Feb 6, 2023 3:00am